28.02.2017
- UK pharmaceutical group Mundipharma is gearing up to launch Truxima (rituximab), a biosimilar from South Korea’s Celltrion, for the treatment of certain cancers and inflammatory...
02.05.2013
- Europe's pharmaceutical industry is in the midst of fundamental change and threats appear from a wide-range of sources: demand and growth potential is increasingly shifting to the...
